Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sustained-release metronidazole for peri-implantitis treatment
IRCT20211103052960N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of metronidazole in peri-implantitis, sponsored by Tabriz University of Medical Sciences. Started Dec 2021; status: completed.
02
Drugs
metronidazole
03
Conditions
peri-implantitis
Beyond the preview
Go deeper on IRCT20211103052960N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211103052960N1.